Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
Marco Solmi,1 Giorgio Pigato,2 John M Kane,3,4 Christoph U Correll3–5 1Neuroscience Department, Psychiatry Unit, University of Padua, Padua, Italy; 2Psychiatry Unit, Padua Hospital, Padua, Italy; 3Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, NY, US...
Main Authors: | Solmi M, Pigato G, Kane JM, Correll CU |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-05-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/treatment-of-tardive-dyskinesia-with-vmat-2-inhibitors-a-systematic-re-peer-reviewed-article-DDDT |
Similar Items
-
Overcoming barriers to effective management of tardive dyskinesia
by: Caroff SN
Published: (2019-04-01) -
Valbenazine: Drug review
by: Mahanjit Konwar, et al.
Published: (2017-01-01) -
Tardive dyskinesia: Prevention and newer management strategies
by: Sreelakshmi Vaidyanathan, et al.
Published: (2020-01-01) -
Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease
by: Dean M, et al.
Published: (2018-02-01) -
Lecithin Therapy for Tardive Dyskinesia
by: Beckham, Barbara
Published: (1981)